Searchable abstracts of presentations at key conferences in endocrinology

ea0059ep83 | Neuroendocrinology and pituitary | SFEBES2018

A disappearing act in the pituitary fossa with recovery from panhypopituitarism

Goodchild Emily , Evanson Jane , Drake William , Glynn Nigel

A 36-year-old, previously healthy, man presented with several weeks’ history of gradually worsening headache. He attended A&E after he was woken by sudden worsening of the headache, associated with vomiting and pre-syncopal symptoms. Investigations revealed severe hyponatraemia - serum Na 109 mmol/L. He was also severely hypocortisolaemic – serum cortisol (random) 16 nmol/L, ACTH 19 ng/L. Cranial imaging revealed a 17 mm suprasellar, complex cystic pituitary lesi...

ea0067o36 | Oral Presentations | EYES2019

Unusual cause of gigantism – Growth hormone releasing hormone (GHRH)-secreting pancreatic neuroendocrine tumour in a patient with multiple endocrine neoplasia type 1 (MEN1)

Nadhamuni Vinaya Srirangam , Iacovazzo Donato , Evanson Jane , Trouillas Jacqueline , Kurzawinski Tom , Bhattacharya Satya , Korbonits Marta

Background: Gigantism is a rare condition with accelerated growth in childhood when the epiphyseal plates are not fused. Most cases are due to growth hormone (GH) secretion from a pituitary adenoma. Rarer causes of GH-related gigantism include somatotroph hyperplasia as part of McCune-Albright syndrome, Carney complex, X-linked acrogigantism or ectopic GHRH production.Case presentation: An 18-year-old male with c.249_252delGTCT;p.I85Sfs MEN1 mut...

ea0028p247 | Pituitary | SFEBES2012

A case series of corticotroph macroadenomas and Cushing’s: clinical characteristics and management

O'Toole Sam , Metcalfe Karl , Plowman Piers , Evanson Jane , Carpenter Robert , Drake Will

Background: Pituitary macroadenomas are an uncommon cause of Cushing’s disease. They present with a higher cortisol burden, are more aggressive and harder to cure and manage than microadenomas.Aims: To review the demographics, clinical features, biochemistry, radiology and required treatment modalities of a single-centre case series of corticotroph macroadenomas.Methods: Retrospective analysis and review of the case records of...

ea0065p289 | Neuroendocrinology | SFEBES2019

Does volumetric MRI (3D-SGE sequence) imaging enhance diagnostic rates in Cushing’s disease?

Gul Fidan , Stiles Craig , Dorward Neil , Grieve Joan , Druce Maralyn , Akker Scott , Waterhouse Mona , Evanson Jane , Drake William

Tumour localisation in Cushing’s disease (CD) can be challenging; most are microadenomas and 50% are <5 mm in diameter. They are, therefore, often difficult to detect by conventional MRI. Volumetric MRI (3D-SGE, spoiled-gradient echo 3D sequence) is a high spatial resolution scanning technique which uses very thin slices (1 mm). Theoretically, this increases the probability of finding small pituitary lesions when compared to conventional (spin-echo, SE) MRI techniques...

ea0013p54 | Clinical practice/governance and case reports | SFEBES2007

Safety of growth hormone replacement in patients with non-irradiated pituitary and peri-pituitary tumours

Chung Teng-Teng , Evanson Jane , Monson John P , Besser Mike , Grossman Ashley B , Akker Scott A , Walker Dorothy , Drake William M

Background/objective: Published data suggest that growth hormone replacement (GHR) may be safely given to patients with hypopituitarism consequent upon a pituitary/peri-pituitary tumour. However, to date, these series have included a preponderance of patients treated with external pituitary irradiation. We have performed a retrospective study to evaluate the recurrence rate in a group of patients with pituitary/peripituitary tumours treated with GHR.Meth...

ea0073aep495 | Pituitary and Neuroendocrinology | ECE2021

Efficacy and safety of cyberknife stereotactic radiosurgery in acromegaly

Seguna Desiree , Akker Scott A , Ahlquist James , Pal Aparna , Brooke Antonia , Lewis Rachel , Plowman Nick , Evanson Jane , Drake William Martyn

ObjectiveActive acromegaly is associated with increased mortality. While surgery is the mainstay of treatment, it is not always curative. In selected cases, CyberKnife stereotactic radiosurgery (CK SRS) can be used as adjuvant treatment in patients with persistent disease.DesignThis is a retrospective review of the biochemical and imaging characteristics for patients with active acromegaly treated with CK SRS...

ea0065p144 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

The yield and cost of radiological screening in von Hippel–Lindau disease

McMillan Timothy , Sahdev Anju , Evanson Jane , McAndrew Lorraine , Martin Lee , Paraskevopoulos Dimitrios , Bull Jonathan , Parvanta Laila , Gevers Evelien , Drake William , O'Toole Samuel

Introduction: Patients with the familial cancer syndrome von Hippel–Lindau disease (VHL) are enrolled in radiological screening programmes which aim to identify tumour development at an early stage. This facilitates timely intervention to lesions when the risk of metastatic spread is low and when they are conducive to less-invasive and parenchymal-sparing interventions, thereby minimising treatment-related morbidity. A number of international screening protocols exist, al...

ea0051oc5.1 | Oral Communications 5 | BSPED2017

New insights into the preoperative localisation of corticotroph adenomas in paediatric Cushing’s disease (CD)

Wilkinson Ingrid C.E. , Evanson Jane , Matson Matthew , Miszkiel Katherine , Grieve Joan , Sabin Ian , Afshar Farhad , Martin Lee , Grossman Ashley B. , Akker Scott , Savage Martin O. , Drake William M. , Storr Helen L.

Introduction: Selective transsphenoidal microadenomectomy (TSS) is the first-line treatment of paediatric Cushing’s disease (CD). Corticotroph adenomas in children are often small and difficult to visualize. We aimed to assess the utility of pituitary MRI and bilateral inferior petrosal sinus sampling (BIPSS) in confirming the diagnosis of CD and the localisation of the adenoma. We also report our early experience of STEALTH MRI (volumetric T1 weighted, contrast-enhanced ...

ea0066oc4.4 | Oral Communications 4 | BSPED2019

A novel clinical risk score that accurately predicts recurrence of craniopharyngioma – a multicentre cohort study

Kyprianou Nikolina , Blackburn James , Tan Rachael , Korbonits Marta , Dattani Mehul , Dutta Pinaki , Bhansali Anil , Rai Ashutosh , Ribalta Teresa , Bulfamante Gaetano Pietro , Massa Valentina , Roncaroli Federico , Evanson Jane , Skoric Tanja , Kastelan Darko , Gnanalingham Kanna , Mitchell Rod , Bulfamante Antonio Mario , Argente Jesus , Goycoolea Andres , Torales Jorge , Biagetti Betina , Audi Laura , Resmini Eugenia , Webb Susan M , Kapoor Ritika R , Chandler Christopher , Sampron Nicolas , Preda Cristina , Ahmad Amar , Gevers Evelien F Pease , Gaston-Massuet Carles

Introduction: Craniopharyngiomas (CPs) are histologically benign tumours but are clinically associated with significant morbidity and mortality. Recurrence of CPs is known to influence mortality, but apart from the extent of surgical resection, no clinical characteristics have been shown to predict recurrence. Complete resection is difficult due to their infiltrative behaviour and unacceptable morbidity. Thus, predictors of risk of recurrence are needed....